A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2011
11/22/2011	US8063108 Method for modulating microbial quorum sensing
11/22/2011	US8063107 Use of trans-pellitorin as flavor substance
11/22/2011	US8063106 ApoE mimetic agents
11/22/2011	US8063105 Renin inhibitors
11/22/2011	US8063104 Guanidine derivatives as inhibitors of DDAH
11/22/2011	US8063103 Polymorphs of acyl sulfonamides
11/22/2011	US8063102 Tetrahydronaphthalen-2-ol derivatives
11/22/2011	US8063101 Carotenoid analogs and derivatives for the prevention of platelet aggregation
11/22/2011	US8063100 Process for the synthesis of strontium ranelate and its hydrates
11/22/2011	US8063099 Trans-3-aza-bicyclo[3.1.0]hexane derivatives
11/22/2011	US8063098 GlyT1 receptor antagonists
11/22/2011	US8063097 Compositions and methods for regulating mammalian keratinous tissue
11/22/2011	US8063096 Spirocyclic 3-phenyl-3substituted-4-ketolactams and-lactones
11/22/2011	US8063095 IAP BIR domain binding compounds
11/22/2011	US8063094 Anti-cytokine heterocyclic compounds
11/22/2011	US8063093 Potassium channel blockers and uses thereof
11/22/2011	US8063091 Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
11/22/2011	US8063090 Mineralocorticoid receptor modulators
11/22/2011	US8063089 Inhibit the multimerization of nucleophosmin; cancer
11/22/2011	US8063088 Imidazolidine derivatives
11/22/2011	US8063087 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazole-2-ones and, 4-(substituted cycloalkylmethyl) imidazole-2-ones and related compounds
11/22/2011	US8063086 Modulators of alpha2B and/or alpha2C adrenergic receptors; alleviate chronic pain, allodynia, muscle spasticity, diarrhea, neuropathic pain; 4-(substituted cycloalkylmethyl)imidazole-2-thione and 4-(substituted cycloalkenylmethyl)imidazole-2-thione compounds
11/22/2011	US8063085 Substituted hydantoins
11/22/2011	US8063084 Heterocyclic compounds suitable for the treatment of diseases related to elevated lipid levels
11/22/2011	US8063083 Method for treating non-Hodgkin's lymphoma
11/22/2011	US8063082 Certain chemical entities, compositions, and methods
11/22/2011	US8063081 Aryl carbonyl derivatives as therapeutic agents
11/22/2011	US8063080 Inhibitors of ion channels
11/22/2011	US8063079 Cyclopropyl compounds
11/22/2011	US8063078 Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
11/22/2011	US8063077 Factor Xa inhibitors
11/22/2011	US8063076 monosulfate salt; crystalline and amorphous forms; metabotropic glutamate receptor 5 modulator (mGluR5) to treat e.g. Fragile X syndrome, incontinence, obesity, autism, anxiety
11/22/2011	US8063075 Pyrrolidine ether derivatives as NK3 receptor antagonists
11/22/2011	US8063074 Polymorphic forms of esomeprazole sodium
11/22/2011	US8063073 2-pyridone derivatives as neutrophil elastase inhibitors and their use
11/22/2011	US8063072 Heterocyclic antiviral compounds
11/22/2011	US8063071 Chemical compounds
11/22/2011	US8063070 Bicyclic benzamides of 3-or 4-substituted 4-(aminomethyl)-piperidine derivatives
11/22/2011	US8063069 Drug for gastrointestinal disorders; cis-4-amino-5-chloro-2,3-dihydro-N-[1-(3-methoxypropyl)-4-piperidinyl]-7-benzofurancarboxamide, N-oxide monohydrate
11/22/2011	US8063068 Arylvinylazacycloalkane compounds and methods of preparation and use thereof
11/22/2011	US8063067 Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
11/22/2011	US8063065 Azaindazole compounds as CCR1 receptor antagonists
11/22/2011	US8063064 Non-nucleoside reverse transcriptase inhibitors
11/22/2011	US8063063 Immunopotentiating compounds
11/22/2011	US8063062 Compounds with a combination of cannabinoid-CB1 antagonism and acetylcholinesterase inhibition
11/22/2011	US8063061 6-(2-amino-1,3-thiazol-4-yl)-3-(2,4-dichlorophenyl)-1-methyl-1,9-dihydro-2H-pyrido[2,3-b]indol-2-one; affinity for GABAA-receptor-associated omega modulatory sites
11/22/2011	US8063060 R(−)-11-hydroxyaporphine derivatives and uses thereof
11/22/2011	US8063059 Use of compositions containing kappa-opioid receptor antagonists for the treatment of dissociative disorders
11/22/2011	US8063058 Inhibitors of syk and JAK protein kinases
11/22/2011	US8063057 Multicyclic amino acid derivatives and methods of their use
11/22/2011	US8063056 Anti-cancer cyclopenta [g]quinazonline compounds
11/22/2011	US8063055 Substituted pyridone compounds and methods of use
11/22/2011	US8063054 Method of treatment of retinal ischemia with diazoxide
11/22/2011	US8063053 1-(arylsulfonyl)-4-(piperazin-1-yl)-1H-benzimidazoles as 5-hydroxytryptamine-6 ligands
11/22/2011	US8063052 Wound healing
11/22/2011	US8063051 9-substituted-8-oxo-adenine compounds as toll-like receptor (TLR7) modulators
11/22/2011	US8063050 Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
11/22/2011	US8063049 Inhibitors of MEK
11/22/2011	US8063048 Acetylenyl-pyrazolo-pyrimidine derivatives
11/22/2011	US8063047 Pyridazine compounds and methods
11/22/2011	US8063046 Benzamide derivative
11/22/2011	US8063045 Fluoropyrrolidines having dipeptidyl peptidase enzyme inhibitory activity
11/22/2011	US8063044 Pyrazole derivatives
11/22/2011	US8063043 Salts of N-[6-cis-2,6-dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4′-(trifluoromethoxy)[1,1′-biphenyl]-3-carboxamide
11/22/2011	US8063042 Heterocyclic compounds
11/22/2011	US8063041 Polymorphic Form D of bazedoxifene acetate and methods of preparing same
11/22/2011	US8063040 Triazabenzo[E]azulene derivatives for the treatment of tumors
11/22/2011	US8063039 3-aminopyrrolidone derivatives
11/22/2011	US8063038 Heterocyclic condensed compounds useful as antidiuretic agents
11/22/2011	US8063037 Progesterone receptor modulators
11/22/2011	US8063036 Benzamides and related inhibitors of factor Xa
11/22/2011	US8063035 Triazolyl aminopyrimidine compounds
11/22/2011	US8063034 Oxadiazole derivatives and thiadiazole derivatives having neovascularization inhibitory activity
11/22/2011	US8063033 Therapeutic beta-lactams
11/22/2011	US8063032 Histamine H3 inverse agonists and antagonists and methods of use thereof
11/22/2011	US8063031 Implants and methods for treating inflammation-mediated conditions of the eye
11/22/2011	US8063030 Extended cycle multiphasic oral contraceptive method
11/22/2011	US8063029 Pharmaceutical composition
11/22/2011	US8063028 Heterocyclic antiviral compounds
11/22/2011	US8063027 Surgical compositions for reducing the incidence of adhesions
11/22/2011	US8063026 Method of palliating lower urinary tract infections by treatment with mannan oligosaccharides
11/22/2011	US8063025 Nucleoside prodrugs and uses thereof
11/22/2011	US8063024 Use of S-adenosylmethionine, vitamin E, and vitamin C for the treatment of oxidative liver injury and insulin resistance
11/22/2011	US8063023 Administering polynucleotides to wound
11/22/2011	US8063021 Ketolide anti-infective compounds
11/22/2011	US8062679 Composition for maintaining androgen and androgen-like uptake potential by cells
11/22/2011	US8062677 Methods and compositions for the sustained release of chromium
11/22/2011	US8062666 Extended release compositions comprising as active compound venlafaxine hydrochloride
11/22/2011	US8062665 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1 ,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
11/22/2011	US8062664 Process for preparing formulations of lipid-regulating drugs
11/22/2011	US8062659 Chewable; organoleptic; partially hydrolyzed guar gum; no need for ingestion aid; compression molding
11/22/2011	US8062656 Methods of treating disease with nitric oxide (NO)-releasing polymers and soluble no-releasing nitrosamines
11/22/2011	US8062653 Controlled release of nitric oxide and drugs from functionalized macromers and oligomers
11/22/2011	US8062652 Compositions and methods for treating precocious puberty
11/22/2011	US8062650 Biologically inhibiting material a method of producing said material as well as the use of said material for inhibiting live cells
11/22/2011	US8062649 Hydroalcoholic compositions thickened using polymers
11/22/2011	US8062648 Formulations containing melatonin, ginkgo biloba, and biotin
11/22/2011	US8062643 Use of neurotoxin therapy for treatment of urologic and related disorders
11/22/2011	US8062631 Oil-in-water formulation: a skin protectant composition, a silicone-based skin protectant composition, a humectant-excipient, a non-ionic emulsifier a chelating compound, a quaternary ammonium salt, a film-forming emollient
11/22/2011	US8062627 Bronchodilator; side efect reduction

1 ... 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 ... 7860